Marlborough, Mass.-based Boston Scientific’s new Endura Weight Loss Solutions offers minimally invasive procedures for patients who want alternatives to diet, medication and bariatric surgery.

Shares of WW International Inc., the company known as WeightWatchers, reversed their early gains Monday despite better-than-expected second-quarter revenue amid robust demand for GLP-1 obesity ...

Shares of WW International Inc., the company known as WeightWatchers, pared back their early gains Monday despite better-than ...

Scientists are looking into alternative weight loss solutions beyond GLP-1 medications like Mounjaro, Ozempic and Wegovy ...

GLP-1 weight-loss drugs have already taken the Europe storm, altering consumer eating habits. Even the eating habits of GLP-1 ...

Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and ...

The product is viewed by the CPG giant as a “one-of-a-kind opportunity” to help consumers rebuild or maintain muscle they ...

Drivers of revenue growth included more customers using multiple chronic condition programs as well as strong adoption of GLP ...

Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 medications.

Researchers have found a potential game-changing way to help people lose weight and control blood sugar without the unpleasant side effects of today’s popular drugs like Ozempic.

Here are five oral obesity candidates that, according to Mizuho’s Graig Suvannavejh, could change the weight loss game.